Cardiovascular Research Institute, University of California San Francisco, San Francisco, CA, 94158, USA.
Biophysics Graduate Program, University of California San Francisco, San Francisco, CA, 94158, USA.
Nat Commun. 2023 Jun 19;14(1):3543. doi: 10.1038/s41467-023-38864-0.
PEAK pseudokinases are molecular scaffolds which dimerize to regulate cell migration, morphology, and proliferation, as well as cancer progression. The mechanistic role dimerization plays in PEAK scaffolding remains unclear, as there are no structures of PEAKs in complex with their interactors. Here, we report the cryo-EM structure of dimeric PEAK3 in complex with an endogenous 14-3-3 heterodimer. Our structure reveals an asymmetric binding mode between PEAK3 and 14-3-3 stabilized by one pseudokinase domain and the SHED domain of the PEAK3 dimer. The binding interface contains a canonical phosphosite-dependent primary interaction and a unique secondary interaction not observed in previous structures of 14-3-3/client complexes. Additionally, we show that PKD regulates PEAK3/14-3-3 binding, which when prevented leads to PEAK3 nuclear enrichment and distinct protein-protein interactions. Altogether, our data demonstrate that PEAK3 dimerization forms an unusual secondary interface for 14-3-3 binding, facilitating 14-3-3 regulation of PEAK3 localization and interactome diversity.
PEAK 假激酶是分子支架,通过二聚化调节细胞迁移、形态和增殖以及癌症进展。PEAK 支架中二聚化所起的机械作用尚不清楚,因为没有 PEAK 与其相互作用物形成复合物的结构。在这里,我们报告了与内源性 14-3-3 异二聚体复合的二聚体 PEAK3 的冷冻电镜结构。我们的结构揭示了 PEAK3 和 14-3-3 之间的不对称结合模式,该模式由一个假激酶结构域和 PEAK3 二聚体的 SHED 结构域稳定。结合界面包含一个典型的磷酸化依赖性主要相互作用和一个在以前的 14-3-3/客户复合物结构中未观察到的独特的次要相互作用。此外,我们表明 PKD 调节 PEAK3/14-3-3 结合,当这种结合被阻止时,会导致 PEAK3 核富集和不同的蛋白质-蛋白质相互作用。总之,我们的数据表明,PEAK3 二聚化形成了 14-3-3 结合的异常次要界面,促进了 14-3-3 对 PEAK3 定位和互作组多样性的调节。